Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.110
+0.040 (3.74%)
Sep 2, 2026, 2:33 PM EDT - Market open
Immuron Market Cap
Immuron has a market cap or net worth of $8.55 million as of September 2, 2026. Its market cap has decreased by -17.82% in one year.
Market Cap
8.55M
Enterprise Value
2.23M
1-Year Change
-17.82%
Ranking
Category
Stock Price
$1.11
ChartMarket Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $8.55M, a decrease of -69.58%. That is a compound annual growth rate of -12.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 8.60M | 91.11% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Traws Pharma | 9.07M |
| Imunon | 8.87M |
| CNS Pharmaceuticals | 8.62M |
| Exicure | 8.54M |
| Skye Bioscience | 8.41M |
| Soligenix | 8.37M |
| Bolt Biotherapeutics | 7.68M |
| Alzamend Neuro | 7.57M |